During the past decade, Ars Rheumatica Sp. Z.o.o. conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ars Rheumatica Sp. Z.o.o." #1 sponsor was "Galapagos NV" with 2 trials, followed by "Astellas Pharma Global Development, Inc." with 1 trials sponsored, "Astellas Pharma Inc" with 1 trials sponsored, "C.T. Development America, Inc." with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ars Rheumatica Sp. Z.o.o." #1 collaborator was "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Ars Rheumatica Sp. Z.o.o." are "Rheumatoid Arthritis" (3 trials), "Arthritis, Rheumatoid" (2 trials) and "Amyloidosis" (1 trials). Many other conditions were trialed in "Ars Rheumatica Sp. Z.o.o." in a lesser frequency.

Most popular intervention types in "Ars Rheumatica Sp. Z.o.o." are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "peficitinib" (2 trials), "Etanercept" (1 trials), "Filgotinib" (1 trials) and "GLPG0634" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ars Rheumatica Sp. Z.o.o." are 6 trials for "All" genders.

Currently, there are NaN active trials in "Ars Rheumatica Sp. Z.o.o.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Ars Rheumatica Sp. Z.o.o., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ars Rheumatica Sp. Z.o.o., 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".